Ocugen Inc Co.Nasdaq Target price , explosive Level, Resistance level = 1.0600
Buying level now .
Accumulation zone now .
Key facts today
Next report date
β
Report period
β
EPS estimate
β
Revenue estimate
β
β0.18β―USD
βͺβ63.08β―Mβ¬β―USD
βͺ6.04β―Mβ¬β―USD
βͺ283.71β―Mβ¬
About Ocugen, Inc.
ο»ΏSector
CEO
Shankar Musunuri
Headquarters
Malvern
Website
Founded
2013
FIGI
BBG00194VJB1
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.
OCUGEN Bullish SignsOCGN beautiful Elliott-Wave(W-X-Y) correction followed by a RSI-divergence in the last Wave(c).
Future outlook is very bullish! Pullbacks could still be bought in my eyes if someone still wants to get into the market.
OCGN Elliott-Wave AnalysisPrice probaly established the bottom on the 23. Oct
Great upside potential for the future!
Ocugen Inc Co.Nasdaq Future Target prices on Chart.
I believe Mr. BILL GATES starts investing π° in this stock
We will see massive actions next days starting from today π
Ocugen Inc Co.Nasdaq Cash and buy now π€π₯π₯π₯π₯π
It will hit 1.000 $ and break up this level π
OCGN Ocugen Options Ahead of EarningsIf you haven`t bought OCGN during the Covid pandemic:
Now analyzing the options chain and the chart patterns of OCGN Ocugen prior to the earnings report this week,
I would consider purchasing the 1usd strike price Calls with
an expiration date of 2024-11-15,
for a premium of approximately $0.08.
I
Ocugen Inc Co.Nasdaq Explosive Level = 1.0900
Buy and be investor, who never knows what is the news π€ππ―π₯π₯π₯π£π
See all ideasΒ
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
ο»ΏThe current price of OCGN is 1.01Β USD β it has increased by 8.88% in the past 24 hours. Watch Ocugen, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Ocugen, Inc. stocks are traded under the ticker OCGN.
OCGN stock has risen by 10.88% compared to the previous week, the month change is a 9.09% rise, over the last year Ocugen, Inc. has showed a 165.01% increase.
We've gathered analysts' opinions on Ocugen, Inc. future price: according to them, OCGN price has a max estimate of 8.00Β USD and a min estimate of 4.00Β USD. Watch OCGN chart and read a more detailed Ocugen, Inc. stock forecast: see what analysts think of Ocugen, Inc. and suggest that you do with its stocks.
OCGN reached its all-time high on Dec 3, 2014 with the price of 778.20Β USD, and its all-time low was 0.17Β USD and was reached on Jun 1, 2020. View more price dynamics on OCGN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
OCGN stock is 13.00% volatile and has beta coefficient of 1.81. Track Ocugen, Inc. stock price on the chart and check out the list of the most volatile stocks β is Ocugen, Inc. there?
Today Ocugen, Inc. has the market capitalization of βͺ310.89β―Mβ¬, it has increased by 9.02% over the last week.
Yes, you can track Ocugen, Inc. financials in yearly and quarterly reports right on TradingView.
Ocugen, Inc. is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
OCGN earnings for the last quarter are β0.06Β USD per share, whereas the estimation was β0.06Β USD resulting in a 0.00% surprise. The estimated earnings for the next quarter are β0.06Β USD per share. See more details about Ocugen, Inc. earnings.
Ocugen, Inc. revenue for the last quarter amounts to βͺ1.14β―Mβ¬Β USD, despite the estimated figure of βͺ400.00β―Kβ¬Β USD. In the next quarter, revenue is expected to reach βͺ400.00β―Kβ¬Β USD.
OCGN net income for the last quarter is βͺβ15.28β―Mβ¬Β USD, while the quarter before that showed βͺβ11.92β―Mβ¬Β USD of net income which accounts for β28.14% change. Track more Ocugen, Inc. financial stats to get the full picture.
No, OCGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 65.00 employees. See our rating of the largest employees β is Ocugen, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ocugen, Inc. EBITDA is βͺβ53.50β―Mβ¬Β USD, and current EBITDA margin is βͺβ1.07β―Kβ¬%. See more stats in Ocugen, Inc. financial statements.
Like other stocks, OCGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ocugen, Inc. stock right from TradingView charts β choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ocugen, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future β according to the 1 month rating Ocugen, Inc. stock shows the sell signal. See more of Ocugen, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.